Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Bioactivx secures $3M in Series A funding for its synthetic wound-care technology, co-led by Martin Krupp and Cocoon Capital, to expand manufacturing and regulatory teams in Singapore.

PRIVATEAug 26, 2026•about 4 hours ago

Amount Raised

$3 Million

Round Type

Series A

SingaporeBiotechnologymedical devices

Investors

Cocoon CapitalMartin Krupp

Description

Bioactivx, a deep-tech startup from Singapore, has raised $3 million in a Series A round to develop its Bioactiv® Matrix synthetic wound-care technology. The funding will support manufacturing expansion, regulatory team strengthening, and clinical trials. The company aims for regulatory approval in Singapore and plans to launch in Q4 2026. This round brings total funding to $4.9 million.

Company Information

Company

BioactivX

Location

Singapore, Southeast Asia, Singapore

About

BioactivX is a Singapore-based biotech startup focused on developing innovative solutions in the biotechnology sector. The company aims to leverage advanced science to create impactful products. With their recent funding, they plan to expand their research and development initiatives. This seed round, led by Cocoon Capital, marks a critical step for their growth.

Don't miss BioactivX's next move

Get an email the moment BioactivX raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for BioactivX's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

BioactivX raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.